Cas no 85079-48-7 (Pumiliotoxin)
Pumiliotoxin Chemical and Physical Properties
Names and Identifiers
-
- brevetoxin pbtx-3
- Brevetoxin 3
- [3H]-PbTx 3
- Brevetoxin PbTx 3
- Brevetoxin T17
- brevetoxin-3
- GB 3
- GB 3 toxin
- PbTx 3
- Ptychodiscus brevis toxin 3
- T-17 toxin
- Toxin T-17
- Pumiliotoxin
- Brevetoxin PbTx-3, Ptychodiscus brevis
- PbTx-3
- HY-12545
- CS-0012001
- AKOS040732657
- CHEMBL1097210
- brevetoxin GB-3
- (21Z)-12-hydroxy-14-[2-(hydroxymethyl)prop-2-enyl]-1,3,11,24,31,41,44-heptamethyl-2,6,10,15,19,25,29,34,38,43,47-undecaoxaundecacyclo[26.22.0.03,26.05,24.07,20.09,18.011,16.030,48.033,46.035,44.037,42]pentaconta-21,40-dien-39-one
- Brevetoxin T 17
- Brevetoxin B, 42-deoxo-42-hydroxy-
- Dihydrobrevetoxin B
- BKMHDYJRAAJTAD-KTKRTIGZSA-N
- brevetoxin T-17
- T17 toxin
- DTXSID001019886
- 42-Deoxo-42-hydroxybrevetoxin B
- 85079-48-7
- T 17
- DA-71728
-
- Inchi: 1S/C50H72O14/c1-25(24-51)14-28-17-37(52)50(8)41(54-28)19-33-34(61-50)18-32-29(55-33)10-9-12-46(4)42(58-32)23-49(7)40(62-46)21-39-47(5,64-49)13-11-30-44(60-39)26(2)15-31-36(56-30)22-48(6)38(57-31)20-35-45(63-48)27(3)16-43(53)59-35/h9-10,16,26,28-42,44-45,51-52H,1,11-15,17-24H2,2-8H3/b10-9-/t26-,28-,29?,30?,31?,32?,33?,34?,35?,36?,37+,38?,39?,40?,41?,42?,44?,45?,46+,47-,48+,49+,50+/m1/s1
- InChI Key: BKMHDYJRAAJTAD-UNMWAESESA-N
- SMILES: O1[C@]2(C)CCC3C([C@H](C)CC4C(C[C@@]5(C)C(CC6C(C(C)=CC(=O)O6)O5)O4)O3)OC2CC2[C@]1(C)CC1[C@](C)(CC=CC3C(CC4C(CC5[C@](C)([C@H](C[C@@H](CC(=C)CO)O5)O)O4)O3)O1)O2 |c:45|
Computed Properties
- Exact Mass: 896.49200
- Monoisotopic Mass: 896.49220697g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 14
- Heavy Atom Count: 64
- Rotatable Bond Count: 3
- Complexity: 1910
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 23
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 1
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 159
- XLogP3: 3.8
Experimental Properties
- PSA: 159.06000
- LogP: 5.26550
Pumiliotoxin Security Information
- Hazardous Material transportation number:UN 3172
- HazardClass:6.1(a)
- PackingGroup:I
- Safety Term:6.1(a)
Pumiliotoxin Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | B275782-100μg |
Pumiliotoxin |
85079-48-7 | ≥95% | 100μg |
¥2102.90 | 2023-09-04 | |
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | 07576-0.5ML |
Pumiliotoxin |
85079-48-7 | 20μg/g in acetonitrile (nominal concentration), certified reference material, | 0.5ML |
¥3412.01 | 2022-02-23 | |
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | 07576-0.5ML |
85079-48-7 | 0.5ML |
¥3908.14 | 2023-01-16 | |||
| LKT Labs | B6918-100 μg |
Brevetoxin 3 |
85079-48-7 | ≥95% | 100μg |
$518.00 | 2023-04-12 | |
| LKT Labs | B6918-1 mg |
Brevetoxin 3 |
85079-48-7 | ≥95% | 1mg |
$4,414.50 | 2023-07-11 | |
| LKT Labs | B6918-5 mg |
Brevetoxin 3 |
85079-48-7 | ≥95% | 5mg |
$13,832.10 | 2023-07-11 | |
| LKT Labs | B6918-100 μg |
Brevetoxin 3 |
85079-48-7 | ≥95% | 100μg |
$518.00 | 2023-07-11 | |
| LKT Labs | B6918-100g |
Brevetoxin 3 |
85079-48-7 | ≥95% | 100g |
$543.90 | 2024-05-21 | |
| LKT Labs | B6918-1mg |
Brevetoxin 3 |
85079-48-7 | ≥95% | 1mg |
$4635.20 | 2024-05-21 | |
| LKT Labs | B6918-5mg |
Brevetoxin 3 |
85079-48-7 | ≥95% | 5mg |
$14523.70 | 2024-05-21 |
Pumiliotoxin Related Literature
-
David B. Cordes,Alexandra M. Z. Slawin,Stefania Righetto,Denis Jacquemin,Eli Zysman-Colman,Véronique Guerchais Dalton Trans., 2018,47, 8292-8300
-
M. T. Colomer,S. Díaz-Moreno,A. Tamayo,A. L. Ortiz J. Mater. Chem. C, 2018,6, 12643-12651
-
S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115
-
Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
-
H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
Additional information on Pumiliotoxin
Unveiling the Secrets of Pumiliotoxin (CAS No. 85079-48-7): A Natural Alkaloid with Unique Biological Properties
In the realm of natural alkaloids, Pumiliotoxin (CAS No. 85079-48-7) stands out as a fascinating compound with a rich history and intriguing biological activities. Derived from the skin secretions of certain tropical frogs, this molecule has captured the attention of researchers worldwide due to its unique structural features and potential applications in various scientific fields.
The discovery of Pumiliotoxin traces back to studies of poison dart frogs, particularly those belonging to the Dendrobatidae family. These small, brightly colored amphibians produce a cocktail of bioactive compounds as a defense mechanism against predators. Among these compounds, Pumiliotoxin has emerged as one of the most interesting from both a chemical and pharmacological perspective.
Chemically speaking, Pumiliotoxin (CAS No. 85079-48-7) belongs to the class of alkaloids known as pumiliotoxins, which are characterized by their complex polycyclic structures. The compound's molecular architecture features a unique combination of rings and functional groups that contribute to its biological activity. Researchers have identified several analogs and derivatives of Pumiliotoxin, each with slightly different properties and potencies.
Recent scientific interest in Pumiliotoxin has been fueled by its interaction with ion channels in biological systems. Studies suggest that this compound may modulate sodium channels in nerve cells, which has led to investigations into its potential neurological effects. However, it's crucial to note that current research remains at the preclinical stage, focusing primarily on understanding the compound's fundamental mechanisms of action.
The biosynthesis of Pumiliotoxin in its natural sources raises intriguing questions about ecological relationships. Evidence suggests that frogs may acquire the precursor compounds from their diet, particularly from certain arthropods, and then modify them into the active toxins. This discovery has opened new avenues for research into the ecological chemistry of tropical ecosystems and the co-evolution of predators and prey.
From a technical perspective, working with Pumiliotoxin (CAS No. 85079-48-7) requires specialized knowledge and equipment. The compound's stability, solubility characteristics, and handling requirements present unique challenges for researchers. Proper analytical techniques, including advanced chromatography and spectrometry methods, are essential for studying this molecule and its derivatives.
In the pharmaceutical research community, there's growing interest in Pumiliotoxin analogs as potential leads for drug development. The compound's ability to interact with specific biological targets makes it a valuable tool for understanding fundamental physiological processes. However, researchers emphasize the need for extensive modification of the natural compound to improve selectivity and reduce potential side effects.
Environmental scientists have also shown interest in Pumiliotoxin as a marker compound for studying ecosystem health. The presence and concentration of this compound in certain frog populations can provide insights into environmental changes and habitat quality. This application highlights the growing field of chemical ecology and its importance in conservation efforts.
The study of Pumiliotoxin (CAS No. 85079-48-7) intersects with several cutting-edge scientific disciplines, including chemical biology, neuropharmacology, and ecological chemistry. As analytical techniques continue to advance, researchers are able to probe deeper into the mysteries of this compound, uncovering new details about its structure-activity relationships and potential applications.
For those interested in the chemical aspects, Pumiliotoxin presents an excellent case study in natural product chemistry. Its synthesis remains challenging, inspiring new methodological developments in organic chemistry. The compound's structural complexity serves as a testbed for innovative synthetic strategies and catalytic methods.
In recent years, the scientific community has seen increased interest in sustainable sourcing of bioactive natural products like Pumiliotoxin. This has led to explorations of alternative production methods, including biosynthesis in engineered microorganisms and total chemical synthesis. These approaches aim to provide research materials while minimizing impact on natural populations of source organisms.
As research on Pumiliotoxin continues to evolve, it's important to maintain a balanced perspective on its potential and limitations. While the compound offers fascinating insights into chemical biology, any practical applications remain speculative at this stage. The scientific community continues to investigate this molecule with rigorous methodologies and ethical considerations.
The story of Pumiliotoxin (CAS No. 85079-48-7) serves as a reminder of nature's chemical ingenuity. From tropical rainforests to research laboratories, this compound bridges diverse scientific disciplines and continues to inspire new questions about the intersection of chemistry and biology. As technology advances, we can expect to uncover even more secrets hidden within this remarkable molecule.
85079-48-7 (Pumiliotoxin) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)